You need JavaScript to view this

Risk assesment in the context of EC directives on genetically modified organisms

Abstract

The introduction of these new molecular technologies initiated an international discussion on the safety in biotechnology. In 1974 one of the pioneers of this new technology, Paul Berg, expressed his view on the potential risks of recombinant DNA applications in the famous 'Berg letter', leading to a self-imposed moratorium on certain experiments. Following the Berg letter and the Asilomar convention, much international attention has been given to the question of safety in biotechnology. This attention resulted in hundreds of documents, research programmes, guidelines and regulations. This resulted, among others, in two EC Directives on genetically modified organisms: the EC Directive 90/219/EEC on the contained use of genetically modified micro-organisms, and Directive 90/220/EEC on the release of genetically modified organisms. These directives lay down a system for harmonization of risk assessment and risk management with regard to the safety for human health and the environment.
Authors:
Meer, P.J. van der [1] 
  1. Ministry for the Environment (Netherlands)
Publication Date:
Jul 01, 1992
Product Type:
Conference
Report Number:
INIS-XA-N-030
Resource Relation:
Conference: 1992 international conference on risk assessment, London (United Kingdom), 5-9 Oct 1992; Other Information: PBD: 1992; Related Information: In: Risk assessment, session 1-4. International conference 1992. Part 1, 248 pages.
Subject:
60 APPLIED LIFE SCIENCES; 61 RADIATION PROTECTION AND DOSIMETRY; BIOTECHNOLOGY; CONSUMER PRODUCTS; CONSUMER PROTECTION; CONTAMINATION; FOOD; FOOD INDUSTRY; GENETIC ENGINEERING; PUBLIC HEALTH; RISK ASSESSMENT
OSTI ID:
20577158
Research Organizations:
Health and Safety Executive (HSE) (United Kingdom)
Country of Origin:
IAEA
Language:
English
Other Identifying Numbers:
TRN: XA04N0323028695
Availability:
Available from INIS in electronic form
Submitting Site:
INIS
Size:
page(s) 221-226
Announcement Date:

Citation Formats

Meer, P.J. van der. Risk assesment in the context of EC directives on genetically modified organisms. IAEA: N. p., 1992. Web.
Meer, P.J. van der. Risk assesment in the context of EC directives on genetically modified organisms. IAEA.
Meer, P.J. van der. 1992. "Risk assesment in the context of EC directives on genetically modified organisms." IAEA.
@misc{etde_20577158,
title = {Risk assesment in the context of EC directives on genetically modified organisms}
author = {Meer, P.J. van der}
abstractNote = {The introduction of these new molecular technologies initiated an international discussion on the safety in biotechnology. In 1974 one of the pioneers of this new technology, Paul Berg, expressed his view on the potential risks of recombinant DNA applications in the famous 'Berg letter', leading to a self-imposed moratorium on certain experiments. Following the Berg letter and the Asilomar convention, much international attention has been given to the question of safety in biotechnology. This attention resulted in hundreds of documents, research programmes, guidelines and regulations. This resulted, among others, in two EC Directives on genetically modified organisms: the EC Directive 90/219/EEC on the contained use of genetically modified micro-organisms, and Directive 90/220/EEC on the release of genetically modified organisms. These directives lay down a system for harmonization of risk assessment and risk management with regard to the safety for human health and the environment.}
place = {IAEA}
year = {1992}
month = {Jul}
}